Cargando…

Recent insights: mesenchymal stromal/stem cell therapy for acute respiratory distress syndrome

Acute respiratory distress syndrome (ARDS) causes respiratory failure, which is associated with severe inflammation and lung damage and has a high mortality and for which there is no therapy. Mesenchymal stromal/stem cells (MSCs) are adult multi-progenitor cells that can modulate the immune response...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horie, Shahd, Laffey, John G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000Research 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926752/ https://www.ncbi.nlm.nih.gov/pubmed/27408702 http://dx.doi.org/10.12688/f1000research.8217.1

Ejemplares similares

Mesenchymal stem cells - a promising therapy for Acute Respiratory Distress Syndrome
por: Hayes, Mairead, et al.
Publicado: (2012)

Clinical review: Stem cell therapies for acute lung injury/acute respiratory distress syndrome - hope or hype?
por: Hayes, Mairead, et al.
Publicado: (2012)

Advances in mesenchymal stromal cell therapy for acute lung injury/acute respiratory distress syndrome
por: Liu, Chang, et al.
Publicado: (2022)

Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome
por: Tovar, Isabel, et al.
Publicado: (2020)

Recent insight into potential acute respiratory distress syndrome
por: Amin, Zulkifli, et al.
Publicado: (2017)

Mesenchymal stromal cell therapy for acute respiratory distress syndrome due to coronavirus disease 2019
por: Whittaker Brown, Stacey-Ann, et al.
Publicado: (2022)

Cell therapy demonstrates promise for acute respiratory distress syndrome - but which cell is best?
por: Curley, Gerard F, et al.
Publicado: (2013)

Mesenchymal Stem/Stromal Cells: SAFETY OF CORD TISSUE DERIVED MESENCHYMAL STROMAL CELLS IN COVID-19 RELATED ACUTE RESPIRATORY DISTRESS SYNDROME
por: Shaz, B., et al.
Publicado: (2022)

Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome
por: Han, Jibin, et al.
Publicado: (2019)

Fresh and Cryopreserved Human Umbilical-Cord-Derived Mesenchymal Stromal Cells Attenuate Injury and Enhance Resolution and Repair following Ventilation-Induced Lung Injury
por: Horie, Shahd, et al.
Publicado: (2021)

Mesenchymal stromal cell application as an emerging translational medicine for acute respiratory distress syndrome
por: Lee, Hyun Jung, et al.
Publicado: (2020)

Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics
por: Qin, Hua, et al.
Publicado: (2020)

Strategies to Enhance Mesenchymal Stem Cell-Based Therapies for Acute Respiratory Distress Syndrome
por: Han, Jibin, et al.
Publicado: (2019)

Cytokine pre-activation of cryopreserved xenogeneic-free human mesenchymal stromal cells enhances resolution and repair following ventilator-induced lung injury potentially via a KGF-dependent mechanism
por: Horie, Shahd, et al.
Publicado: (2020)

Machine Learning Classifier Models: The Future for Acute Respiratory Distress Syndrome Phenotyping?
por: McNicholas, Bairbre, et al.
Publicado: (2020)

Compliance Phenotypes in Early Acute Respiratory Distress Syndrome before the COVID-19 Pandemic
por: Panwar, Rakshit, et al.
Publicado: (2020)

Umbilical cord-derived CD362(+) mesenchymal stromal cells for E. coli pneumonia: impact of dose regimen, passage, cryopreservation, and antibiotic therapy
por: Horie, Shahd, et al.
Publicado: (2020)

In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome
por: Simonson, Oscar E., et al.
Publicado: (2016)

Understanding the Role of Mesenchymal Stromal Cells in Treating COVID-19 Acute Respiratory Distress Syndrome
por: O’Kane, Cecilia M., et al.
Publicado: (2022)

Enhancing the Efficacy of Mesenchymal Stromal Cells in COVID-19–related Acute Respiratory Distress Syndrome
por: Zhang, Haibo, et al.
Publicado: (2023)

Umbilical Cord-Derived CD362(+) Mesenchymal Stromal Cells Attenuate Polymicrobial Sepsis Induced by Caecal Ligation and Puncture
por: Gonzalez, Hector, et al.
Publicado: (2020)

The efficacy of mesenchymal stromal cell-derived therapies for acute respiratory distress syndrome—a meta-analysis of preclinical trials
por: Wang, Fengyun, et al.
Publicado: (2020)

Concise Review: Mesenchymal Stromal Cell‐Based Approaches for the Treatment of Acute Respiratory Distress and Sepsis Syndromes
por: Johnson, Christian L., et al.
Publicado: (2017)

Mesenchymal stromal cells alleviate acute respiratory distress syndrome through the cholinergic anti-inflammatory pathway
por: Zhang, Xiaoran, et al.
Publicado: (2022)

Presence of comorbidities alters management and worsens outcome of patients with acute respiratory distress syndrome: insights from the LUNG SAFE study
por: Rezoagli, Emanuele, et al.
Publicado: (2022)

In Silico Modeling of Coronavirus Disease 2019 Acute Respiratory Distress Syndrome: Pathophysiologic Insights and Potential Management Implications
por: Das, Anup, et al.
Publicado: (2020)

Sepsis and Acute Respiratory Distress Syndrome: Recent Update
por: Kim, Won-Young, et al.
Publicado: (2016)

Recent advances in understanding acute respiratory distress syndrome
por: Wohlrab, Peter, et al.
Publicado: (2018)

Personalized mechanical ventilation in acute respiratory distress syndrome
por: Pelosi, Paolo, et al.
Publicado: (2021)

Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome
por: Wang, Yan-Yang, et al.
Publicado: (2013)

Role of the adaptive immune response in sepsis
por: Brady, Jack, et al.
Publicado: (2020)

Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome: insights from the LUNG SAFE study
por: Madotto, Fabiana, et al.
Publicado: (2020)

The effect of acute respiratory distress syndrome on bone marrow-derived mesenchymal stem cells
por: Antebi, Ben, et al.
Publicado: (2018)

Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2019)

Mesenchymal stem cell‐derived extracellular vesicles for the treatment of acute respiratory distress syndrome
por: Abraham, Aswin, et al.
Publicado: (2019)

Mesenchymal Stem Cell: Does it Work in an Experimental Model with Acute Respiratory Distress Syndrome?
por: Yilmaz, Sema, et al.
Publicado: (2012)

Repair of acute respiratory distress syndrome by stromal cell administration (REALIST) trial: A phase 1 trial
por: Gorman, Ellen, et al.
Publicado: (2021)

Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome
por: Lin, Feng, et al.
Publicado: (2020)

Five-Year Follow-up after Mesenchymal Stromal Cell–based Treatment of Severe Acute Respiratory Distress Syndrome
por: Simonson, Oscar E., et al.
Publicado: (2020)

Mesenchymal Stromal Cells Attenuate Infection-Induced Acute Respiratory Distress Syndrome in Animal Experiments: A Meta-Analysis
por: Fengyun, Wang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gd4gef0t00iqesehcval459gbq